61
Views
16
CrossRef citations to date
0
Altmetric
Review

Lactogens and estrogens in breast cancer chemoresistance

, , &
Pages 411-422 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Vincent Goffin & Philippe Touraine. (2015) The prolactin receptor as a therapeutic target in human diseases: browsing new potential indications. Expert Opinion on Therapeutic Targets 19:9, pages 1229-1244.
Read now
Ramesh Singh & Yin-Yuan Mo. (2013) Role of microRNAs in breast cancer. Cancer Biology & Therapy 14:3, pages 201-212.
Read now
Lev M Berstein. (2011) Endocrinology of breast cancer: results, tasks and hopes. Expert Review of Endocrinology & Metabolism 6:3, pages 293-297.
Read now

Articles from other publishers (13)

Raja S Alyusuf, Javed F Wazir, Urmil P Brahmi, Abdul Rahman E Fakhro, Zainab A Toorani & Yousef Rezk. (2023) The Pattern of Expression of Human Placental Lactogen Across Normal, Lactational, and Malignant Mammary Epithelium. Cureus.
Crossref
Fayyaz Ahmed, Bushra Ijaz, Zarnab Ahmad, Nadia Farooq, Muhammad Bilal Sarwar & Tayyab Husnain. (2020) Modification of miRNA Expression through plant extracts and compounds against breast cancer: Mechanism and translational significance. Phytomedicine 68, pages 153168.
Crossref
Antonela Sofía Asad, Alejandro Javier Nicola Candia, Nazareno Gonzalez, Camila Florencia Zuccato, Araceli Abt, Santiago Jordi Orrillo, Yael Lastra, Emilio De Simone, Florence Boutillon, Vincent Goffin, Adriana Seilicovich, Daniel Alberto Pisera, María Jimena Ferraris & Marianela Candolfi. (2019) Prolactin and its receptor as therapeutic targets in glioblastoma multiforme. Scientific Reports 9:1.
Crossref
Nira Ben-Jonathan. 2019. Estrogen Receptor and Breast Cancer. Estrogen Receptor and Breast Cancer 343 377 .
Göknil Coşkun, Teodora Djikic, Taha Hayal, Nezaket Türkel, Kemal Yelekçi, Fikrettin Şahin & Ş. Küçükgüzel. (2018) Synthesis, Molecular Docking and Anticancer Activity of Diflunisal Derivatives as Cyclooxygenase Enzyme Inhibitors. Molecules 23:8, pages 1969.
Crossref
Filippo Maffezzoni, Gherardo Mazziotti & Andrea Giustina. 2018. Encyclopedia of Endocrine Diseases. Encyclopedia of Endocrine Diseases 157 164 .
Vincent Goffin. (2017) Prolactin receptor targeting in breast and prostate cancers: New insights into an old challenge. Pharmacology & Therapeutics 179, pages 111-126.
Crossref
Marcus P. Kelly, Carlos Hickey, Sosina Makonnen, Sandra Coetzee, Sumreen Jalal, Yu Wang, Frank Delfino, Jing Shan, Terra B. Potocky, Ishita Chatterjee, Julian Andreev, Arthur Kunz, Christopher D'Souza, Jason T. Giurleo, Thomas Nittoli, Pamela A. Trail, Gavin Thurston & Jessica R. Kirshner. (2017) Preclinical Activity of the Novel Anti-Prolactin Receptor (PRLR) Antibody–Drug Conjugate REGN2878-DM1 in PRLR-Positive Breast Cancers. Molecular Cancer Therapeutics 16:7, pages 1299-1311.
Crossref
Felicitas Lopez Vicchi & Damasia Becu-Villalobos. (2017) Prolactin: The Bright and the Dark Side. Endocrinology 158:6, pages 1556-1559.
Crossref
Keshuo Ding, Yan Yuan, Qing-Yun Chong, Yulu Yang, Rui Li, Xiaoni Li, Xiangjun Kong, Pengxu Qian, Zirui Xiong, Vijay Pandey, Lan Ma, Zhengsheng Wu, Peter E. Lobie & Tao Zhu. (2017) Autocrine Prolactin Stimulates Endometrial Carcinoma Growth and Metastasis and Reduces Sensitivity to Chemotherapy. Endocrinology 158:6, pages 1595-1611.
Crossref
Kuan-Hui Ethan Chen & Ameae M. Walker. (2016) Prolactin inhibits a major tumor-suppressive function of wild type BRCA1. Cancer Letters 375:2, pages 293-302.
Crossref
Yu-Chih Wang & Eing-Mei Tsai. (2012) Role of Estrogen and Xenoestrogen in Chemoresistance of Breast Cancer. Journal of Experimental & Clinical Medicine 4:6, pages 320-324.
Crossref
Philip W. Harvey. (2012) Hypothesis Prolactin is tumorigenic to human breast: dispelling the myth that prolactin-induced mammary tumors are rodent-specific. Journal of Applied Toxicology 32:1, pages 1-9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.